查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1390742

精準醫療市場報告產品、技術、應用（腫瘤學、中樞神經系統、免疫學、呼吸醫學、感染等）、最終用戶和地區 2023-2028

Precision Medicine Market Report Product, Technology, Application (Oncology, Central Nervous System, Immunology, Respiratory Medicine, Infections, and Others), End User, and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年全球精準醫療市場規模達681億美元。展望未來， IMARC Group預計到2028年市場規模將達到1,234億美元，2022-2028年複合年成長率（CAGR）為10.41%。快速的技術進步、研發投資、不斷成長的消費者需求、有利的政府政策的實施、電子健康記錄（EHR）的激增、製藥公司之間的戰略聯盟、慢性病的增加是推動這一趨勢的主要因素。市場。

精準醫療，也稱為個人化醫療，是一種在做出醫療決策時考慮個人獨特的基因組成、環境和生活方式的醫療保健方法。它涉及根據每位患者的具體特徵制定醫療治療和干涉措施，而不是使用一刀切的方法。精準醫學依靠基因組學和其他生物醫學研究領域的進步來識別遺傳變異和生物標記物，幫助預測患者對某些藥物或療法的反應。

基因組學、生物資訊學和醫學影像領域的持續創新為精準醫療提供了必要的工具，從而推動了市場的成長。除此之外，政府和私營部門對研發（R＆D）的投資正在加快精準醫療的發現和實施步伐，從而推動市場成長。與此相適應，更知情和具有健康意識的公眾正在尋求個人化的醫療解決方案，從而推動市場向前發展。除此之外，各國政府越來越認知到精準醫療的潛力，制定政策和法規，促進其採用和標準化，從而有利於市場成長。此外，電子健康記錄（EHR）和其他健康資料存儲庫的激增使醫療保健提供者更容易訪問和分析患者資訊，進一步促進了市場擴張。

精準醫學市場趨勢/促進因素：

技術進步

科技在精準醫療市場中的作用是不可否認的，目前是其成長的主要驅動力之一。基因組學、生物資訊學和醫學影像領域的創新使得以前所未有的準確性分析和解釋大量生物資料成為可能。最新的定序技術可以進行更快速、更具成本效益的基因分析，讓個人化治療更容易實現。生物資訊工具提供強大的演算法來解釋複雜的遺傳訊息，為臨床醫生提供可行的見解。磁振造影 (MRI) 和電腦斷層掃描 (CT) 等醫學影像技術也在不斷發展，可以顯示最微小的細節，有助於診斷和治療計劃。這些技術突破正在產生連鎖反應，不僅推動了醫學科學的發展，也推動了精準醫療市場的發展。

實施各項政府措施並增加資金

資金是推動精準醫療市場的重要催化劑。除此之外，政府和私營部門的財政支持正在加快研發 (R&D) 的步伐，使得探索個人化醫療保健的新途徑成為可能。大型計畫（通常是國際合作）正在啟動，以揭示各種疾病的潛在遺傳和環境因素。專注於開發精準醫療技術或方法的新創公司和研究機構可以獲得贈款和補貼。資本的湧入正在加速新產品和服務的商業化，將市場推向更高的高度。

群眾健康意識不斷增強

知情且具有健康意識的人群正在創造對個人化醫療解決方案的強勁需求，從而成為精準醫療市場的關鍵驅動力。隨著醫療資訊的獲取越來越多，患者正在成為醫療保健旅程的積極參與者，尋求更有針對性和更有效的治療。社群媒體和線上平台正在擴大醫學突破的影響範圍，使患者能夠尋求量身定做的治療方法。消費者行為的轉變迫使醫療保健提供者和製藥公司透過開發更個人化的解決方案來適應這些需求。這反過來又產生了需求和供應的循環，從而推動了市場擴張。

精準醫療產業細分：

IMARC Group提供了全球精準醫療市場報告各細分市場主要趨勢的分析，以及 2023-2028 年全球、區域和國家層面的預測。我們的報告根據產品、技術、應用和最終用戶對市場進行了分類。

按產品分類：

耗材

儀器

服務

該報告根據產品類型對市場進行了詳細的細分和分析。這包括消耗品、儀器和服務。

耗材在精準醫療市場的應用主要出於關鍵零件、高需求、研發、成本效益、客製化和持續創新等幾個原因。

由於技術進步、個人化診斷、藥物開發、研究應用、成本降低、監管支援、意識增強和市場競爭力等幾個引人注目的因素，儀器為精準醫療市場提供了幫助。

由於客製化和個人化、資料分析專業知識、監管合規性、快速技術進步、整體患者護理、專業設備的使用、跨學科合作、品質保證和標準化、長期參與等多種原因，服務被用於精準醫療市場。資料安全和隱私以及成本效率。

按技術分類：

巨量資料分析

生物資訊學

基因定序

藥物發現

伴隨診斷

其他

藥物發現佔據最大市場佔有率

報告還提供了基於該技術的詳細市場細分和分析。這包括巨量資料分析、生物資訊學、基因定序、藥物發現、伴隨診斷等。報告稱，藥物發現佔據了最大的市場佔有率。

藥物發現目前在精準醫學市場的技術領域佔據主導地位，因為它在開發標靶療法方面發揮關鍵作用，而標靶療法是精準醫學的基石。透過利用先進的基因組學和生物資訊學，藥物發現已從廣譜方法轉變為高度客製化的方法，旨在開發更有效且副作用更少的治療方法。這直接影響臨床試驗的成功率，以及新藥的整體成本和上市時間。此外，現代藥物發現中使用的高通量篩選方法和人工智慧（AI）驅動的演算法可以分析大量資料集的模式或標記，從而大大加快尋找合適候選藥物的過程。

按應用分類：

腫瘤學

中樞神經系統 (CNS)

免疫學

呼吸內科

感染

其他

腫瘤學佔據最大市場佔有率

報告還提供了基於應用程式的詳細市場細分和分析。這包括腫瘤學、中樞神經系統 (CNS)、免疫學、呼吸系統醫學、感染學等。報告稱，腫瘤學佔據最大的市場佔有率。

由於多種因素使其特別適合個人化治療方法，腫瘤學目前在精準醫療市場的應用領域中佔據主導地位。癌症是一種高度異質性的疾病，即使在同一類型的癌症中，也具有不同的基因突變。精準醫學可以識別癌細胞中的特定遺傳標記和突變，使臨床醫生能夠開出更有可能成功的標靶治療。此外，全球癌症的高盛行率需要創新和有效的治療策略，從而推動腫瘤學精準醫學的需求。基因組定序技術的進步也促進了致癌突變的快速識別，加速了標靶藥物和個人化治療計劃的開發。此外，癌症研究正在進行大量投資，為在腫瘤學中廣泛應用精準醫學提供所需的財政支持。因此，癌症生物學的複雜性加上技術和財務因素使腫瘤學成為精準醫療市場中最突出的領域。

按最終用戶分類：

醫院和診所

診斷中心

製藥和生物技術公司

醫療保健 IT 公司

其他

醫院和診所佔據最大的市場佔有率

報告還提供了基於最終用戶的詳細市場細分和分析。這包括醫院和診所、診斷中心、製藥和生物技術公司、醫療保健 IT 公司等。報告顯示，醫院和診所佔據了最大的市場。

由於多種因素的綜合作用，醫院和診所目前在精準醫療市場的最終用戶領域佔據主導地位，這些因素使得這些環境特別適合實施個人化醫療保健解決方案。醫院和診所擁有精準醫療所需的基礎設施和先進醫療技術，例如專業診斷設備和先進的資料分析平台。此外，這些機構受益於多學科團隊的專業知識，包括遺傳學家、資料科學家和專業臨床醫生，他們可以協作解釋複雜的資料以指導治療計劃。此外，醫院和診所的患者數量和多樣性為在各種條件和人口統計中應用精準醫療提供了更廣泛的範圍，從而為持續改進和研究提供了強大的資料集。這些要素共同創造了一個有利於精準醫療的採用和成功實施的生態系統，從而有助於醫院和診所在市場上的主導地位。

按地區分類：

北美洲

美國

加拿大

亞太

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

北美佔據明顯主導地位，佔據最大的精準醫療市場佔有率

市場研究報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告稱，北美佔據最大的市場佔有率。

由於創造了有利於成長的環境的因素的綜合作用，北美目前在精準醫療市場的區域領域處於領先地位。該地區擁有強大的醫療基礎設施，配備最先進的醫療技術和研究設施。政府和私營部門的大量資金進一步支持了這一點，為精準醫療領域的研究和發展提供了充足的資源。尤其是美國，一直透過精準醫療計劃等立法措施積極支持精準醫療，從而促進創新和標準化。此外，北美擁有高水準的消費者醫療保健意識和教育水準。民眾精通科技且注重健康，推動了對更個人化醫療解決方案的需求。所有這些因素共同促成了北美在全球精準醫療領域的主導地位。

競爭格局：

精準醫療市場的領導者正在積極參與各種策略性舉措，旨在鞏固其市場地位並推動創新。研究與開發 (R&D) 仍然是其活動的基石，為發現新療法和診斷工具分配了大量投資。其中許多公司還與學術機構、生技公司和醫療保健提供者建立合作和夥伴關係，以加快進步的步伐。此外，隨著大型企業尋求將尖端技術整合到其現有產品組合中，併購變得越來越普遍。這些多方面的努力凸顯了領導企業對塑造精準醫療未來格局的承諾。

該報告對市場競爭格局進行了全面分析。也提供了所有主要公司的詳細資料。市場上的一些主要參與者包括：

阿斯特捷利康公司

拜耳公司

生物梅里埃公司

百時美施貴寶公司

禮來公司

F.霍夫曼-拉羅氏股份公司

照明公司

美國實驗室控股公司

默克公司

諾華公司

輝瑞公司

凱傑公司

奎斯特診斷公司

賽默飛世爾科技公司

最近的發展：

2023年2月，羅氏宣布擴大與楊森生物技術公司（Janssen）的合作，為標靶治療創建伴隨診斷，進一步加強研究和創新活動。

2021 年 12 月，Illumina, Inc. 宣布支持挪威的一項國家精準醫學研究，以評估基於血液的綜合基因組分析 (CGP) 在癌症治療選擇測試中的功效。

2020 年5 月，QIAGEN 推出了新型QIAseq Targeted Mmethyl panel，這是首款也是唯一一款基於NGS 的標靶甲基化分析產品，該產品透過公司專有的單引物延伸技術提高了分析靈敏度和序列靶向能力。

本報告回答的關鍵問題：

  • 迄今為止，全球精準醫療市場表現如何，未來幾年將如何表現？
  • 全球精準醫療市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球精準醫療市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的精準醫療市場？
  • 基於產品的市場區隔是什麼？
  • 精準醫療市場最有吸引力的產品是什麼？
  • 什麼是基於技術的市場分割？
  • 精準醫療市場最有吸引力的技術是什麼？
  • 基於應用程式的市場區隔是什麼？
  • 精準醫療市場最具吸引力的應用是什麼？
  • 基於最終用戶的市場區隔是什麼？
  • 正畸耗材市場上哪一個對最終用戶最具吸引力？
  • 全球精準醫療市場競爭格局如何？
  • 全球精準醫療市場的主要參與者/公司有哪些？

本報告回答的關鍵問題：

  • 迄今為止，全球精準醫療市場表現如何，未來幾年將如何表現？
  • 全球精準醫療市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球精準醫療市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的精準醫療市場？
  • 基於產品的市場區隔是什麼？
  • 精準醫療市場最有吸引力的產品是什麼？
  • 什麼是基於技術的市場分割？
  • 精準醫療市場最有吸引力的技術是什麼？
  • 基於應用程式的市場區隔是什麼？
  • 精準醫療市場最具吸引力的應用是什麼？
  • 基於最終用戶的市場區隔是什麼？
  • 正畸耗材市場上哪一個對最終用戶最具吸引力？
  • 全球精準醫療市場競爭格局如何？
  • 全球精準醫療市場的主要參與者/公司有哪些？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球精準醫療市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：按產品分類的市場區隔

  • 耗材
    • 市場走向
    • 市場預測
  • 儀器
    • 市場走向
    • 市場預測
  • 服務
    • 市場走向
    • 市場預測

第 7 章：依科技分類的市場

  • 巨量資料分析
    • 市場走向
    • 市場預測
  • 生物資訊學
    • 市場走向
    • 市場預測
  • 基因定序
    • 市場走向
    • 市場預測
  • 藥物發現
    • 市場走向
    • 市場預測
  • 伴隨診斷
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：按應用分類的市場區隔

  • 腫瘤學
    • 市場走向
    • 市場預測
  • 中樞神經系統 (CNS)
    • 市場走向
    • 市場預測
  • 免疫學
    • 市場走向
    • 市場預測
  • 呼吸內科
    • 市場走向
    • 市場預測
  • 感染
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：最終用戶的市場區隔

  • 醫院和診所
    • 市場走向
    • 市場預測
  • 診斷中心
    • 市場走向
    • 市場預測
  • 製藥和生物技術公司
    • 市場走向
    • 市場預測
  • 醫療保健 IT 公司
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 10 章：按地區分類的市場細分

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • AstraZeneca plc
    • Bayer AG
    • bioMerieux SA
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • F. Hoffmann-La Roche AG
    • Illumina Inc.
    • Laboratory Corporation of America Holdings
    • Merck KGaA
    • Novartis AG
    • Pfizer Inc.
    • Qiagen NV
    • Quest Diagnostics Incorporated
    • Thermo Fisher Scientific Inc.
Product Code: SR112023A4567

Abstract

The global precision medicine market size reached US$ 68.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 123.4 Billion by 2028, exhibiting a growth rate (CAGR) of 10.41% during 2022-2028. Rapid technological advancements, investments in research and development(R&D), increasing consumer demand, the implementation of favorable government policies, surge in electronic health records (EHRs), strategic alliances between pharmaceutical companies, rising chronic diseases are some of the major factors propelling the market.

Precision medicine, also known as personalized medicine, is an approach to healthcare that takes into account an individual's unique genetic makeup, environment, and lifestyle when making medical decisions. It involves tailoring medical treatments and interventions to the specific characteristics of each patient, rather than using a one-size-fits-all approach. Precision medicine relies on advancements in genomics and other fields of biomedical research to identify genetic variations and biomarkers that can help predict a patient's response to certain drugs or therapies.

Ongoing innovations in genomics, bioinformatics, and medical imaging are providing the essential tools for precision medicine, thereby driving the market growth. In addition to this, government and private sector investments in research and development (R&D) are accelerating the pace of discoveries and implementation in precision medicine which in turn is impelling the market growth. In line with this, a more informed and health-conscious public is seeking personalized medical solutions, thus propelling the market forward. Besides this, governments are increasingly recognizing the potential of precision medicine, enacting policies and regulations that facilitate its adoption and standardization thus favoring the market growth. Furthermore, the surge in electronic health records (EHRs) and other health data repositories has made it easier for healthcare providers to access and analyze patient information, further catalyzing market expansion.

Precision Medicine Market Trends/Drivers:

Technological advancements

The role of technology in the precision medicine market is undeniable and currently serves as one of the primary drivers for its growth. Innovations in genomics, bioinformatics, and medical imaging are making it possible to analyze and interpret vast amounts of biological data with unprecedented accuracy. The latest sequencing technologies allow for more rapid and cost-effective genetic analysis, thereby making personalized treatment more accessible. Bioinformatics tools offer robust algorithms to interpret complex genetic information, providing actionable insights for clinicians. Medical imaging techniques like magnetic resonance imaging (MRI) and computerized tomography (CT) scans are also evolving to show even the most minute details, helping in the diagnosis and treatment planning. These technological breakthroughs are creating a ripple effect, advancing not just medical science but also propelling the precision medicine market forward.

The implementation of various government initiatives and increased funding

Funding serves as a significant catalyst in driving the precision medicine market. In addition to this, financial backing from both the government and private sectors is accelerating the pace of research and development (R&D), making it possible to explore new avenues in personalized healthcare. Large-scale projects, often international collaborations, are being initiated to uncover the underlying genetic and environmental factors of various diseases. Grants and subsidies are available for startups and research institutions that focus on developing precision medicine technologies or methodologies. This influx of capital is speeding up the commercialization of new products and services, thereby pushing the market towards greater heights.

The rising health consciousness among the masses

An informed and health-conscious population is creating robust demand for personalized medical solutions, thereby acting as a key driver for the precision medicine market. With increasing access to medical information, patients are becoming active participants in their healthcare journey, seeking more targeted and efficient treatments. Social media and online platforms are amplifying the reach of medical breakthroughs, empowering patients to ask for tailored therapies. The shift in consumer behavior is compelling healthcare providers and pharmaceutical companies to adapt to these demands by developing more personalized solutions. This in turn is generating a cycle of demand and supply that is fueling market expansion.

Precision Medicine Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global precision medicine market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on product, technology, application and end user.

Breakup by Product:

Consumables

Instruments

Services

The report has provided a detailed breakup and analysis of the market based on the product type. This includes consumables, instruments, and services.

Consumables are used in precision medicine market due to several reasons such as essential components, high demand, research and development, cost-effectiveness, customization, and continuous innovation.

Instruments assist the precision medicine market due to several compelling factors such as technological advancements, personalized diagnostics, drug development, research applications, cost reduction, regulatory support, increased awareness and market competitiveness.

Services are used in precision medicine market due to several reasons such as customization and personalization, data analysis expertise, regulatory compliance, rapid technological advancements, holistic patient care, access to specialized equipment, interdisciplinary collaboration, quality assurance and standardization, long-term engagement, data security and privacy, and cost efficiency.

Breakup by Technology:

Big Data Analytics

Bioinformatics

Gene Sequencing

Drug Discovery

Companion Diagnostics

Others

Drug discovery hold the largest share in the market

A detailed breakup and analysis of the market based on the technology has also been provided in the report. This includes big data analytics, bioinformatics, gene sequencing, drug discovery, companion diagnostics, and others. According to the report, drug discovery accounted for the largest market share.

Drug discovery currently dominates the technology segment of the precision medicine market due to its critical role in developing targeted therapies, which are the cornerstone of precision medicine. By leveraging advanced genomics and bioinformatics, drug discovery has moved from a broad-spectrum approach to one that is highly tailored, aiming to develop treatments that are more effective and have fewer side effects. This has a direct impact on the rate of successful clinical trials, as well as the overall cost and time-to-market for new drugs. Furthermore, the high throughput screening methods and artificial intelligence (AI) driven algorithms used in modern drug discovery can analyze enormous data sets for patterns or markers, dramatically speeding up the process of finding suitable drug candidates.

Breakup by Application:

Oncology

Central Nervous System (CNS)

Immunology

Respiratory Medicine

Infections

Others

Oncology holds the largest share in the market

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes oncology, central nervous system (CNS), immunology, respiratory medicine, infections, and others. According to the report, oncology accounted for the largest market share.

Oncology is currently dominating the application segment of the precision medicine market due to a confluence of factors that make it particularly suited for personalized treatment approaches. Cancer is a highly heterogeneous disease with varying genetic mutations, even within the same type of cancer. Precision medicine allows for the identification of specific genetic markers and mutations in cancer cells, enabling clinicians to prescribe targeted therapies that are more likely to succeed. Additionally, the high prevalence of cancer across the globe necessitates innovative and effective treatment strategies, thereby driving demand for precision medicine in oncology. Advances in genomic sequencing technologies have also facilitated the rapid identification of oncogenic mutations, accelerating the development of targeted drugs and personalized treatment plans. Furthermore, significant investments are being made in cancer research, providing the financial backing needed to apply precision medicine widely in oncology. Hence, the intricacies of cancer biology combined with technological and financial factors make oncology the most prominent sector within the precision medicine market.

Breakup by End User:

Hospitals and Clinics

Diagnostic Centers

Pharma and Biotech Companies

Healthcare IT Firms

Others

Hospitals and clinics hold the largest share in the market

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals and clinics, diagnostic centers, pharma and biotech companies, healthcare IT firms, and others. According to the report, hospitals and clinics accounted for the largest market share.

Hospitals and clinics are currently dominating the end-user segment of the precision medicine market due to a confluence of factors that make these settings particularly suited for implementing personalized healthcare solutions. Hospitals and clinics have the infrastructure and access to advanced medical technologies that are essential for precision medicine, such as specialized diagnostic equipment and advanced data analytics platforms. Moreover, these institutions benefit from the expertise of multidisciplinary teams, including geneticists, data scientists, and specialized clinicians, who can collaboratively interpret complex data to guide treatment plans. Furthermore, the patient volume and diversity present in hospitals and clinics offer a broader scope for applying precision medicine across various conditions and demographics, thus providing a robust dataset for continuous improvement and research. Together, these elements create an ecosystem that is conducive to the adoption and successful implementation of precision medicine, thereby contributing to the domination of hospitals and clinics in the market.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest precision medicine market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America is currently leading the regional segment of the precision medicine market due to a confluence of factors that create an environment conducive for growth. The region is home to a robust healthcare infrastructure, equipped with state-of-the-art medical technologies and research facilities. This is further supported by substantial funding from both governmental and private sectors, providing ample resources for research and development in the field of precision medicine. The United States, in particular, has been proactive in endorsing precision medicine through legislative measures, such as the Precision Medicine Initiative, thereby fostering innovation and standardization. Additionally, North America boasts a high level of consumer awareness and education regarding healthcare. The populace is technologically savvy and health-conscious, driving demand for more personalized medical solutions. All these elements collectively contribute to North America's dominant position in the global landscape of precision medicine.

Competitive Landscape:

The leading players in the precision medicine market are actively engaging in a variety of strategic initiatives aimed at consolidating their market position and driving innovation. Research and development (R&D) remain a cornerstone of their activities, with significant investments allocated for the discovery of novel therapies and diagnostic tools. Many of these companies are also entering into collaborations and partnerships with academic institutions, biotechnology firms, and healthcare providers to accelerate the pace of advancements. Furthermore, mergers and acquisitions are becoming increasingly common as larger players seek to integrate cutting-edge technologies into their existing portfolios. These multifaceted efforts underscore the commitment of leading players to shaping the future landscape of precision medicine.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

AstraZeneca plc

Bayer AG

bioMerieux SA

Bristol-Myers Squibb Company

Eli Lilly and Company

F. Hoffmann-La Roche AG

Illumina Inc.

Laboratory Corporation of America Holdings

Merck KGaA

Novartis AG

Pfizer Inc.

Qiagen N.V.

Quest Diagnostics Incorporated

Thermo Fisher Scientific Inc.

Recent Developments:

In February 2023, Roche announced that it has expanded its collaboration with Janssen Biotech Inc. (Janssen) to create companion diagnostics for targeted therapies, further strengthening research and innovation activities.

In December 2021, Illumina, Inc. announced that it is supporting a national precision medicine study in Norway to assess the efficacy of blood-based comprehensive genomic profiling (CGP) in cancer therapy selection testing.

In May 2020, QIAGEN has launched the novel QIAseq Targeted Methyl panels, the first and only NGS-based products for targeted methylation analysis with the increased analytical sensitivity and sequence-targeting capabilities of the company's proprietary Single Primer Extension technology.

Key Questions Answered in This Report:

  • How has the global precision medicine market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global precision medicine market?
  • What is the impact of each driver, restraint, and opportunity on the global precision medicine market?
  • What are the key regional markets?
  • Which countries represent the most attractive precision medicine market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the precision medicine market?
  • What is the breakup of the market based on technology?
  • Which is the most attractive technology in the precision medicine market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the precision medicine market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the orthodontic consumables market?
  • What is the competitive structure of the global precision medicine market?
  • Who are the key players/companies in the global precision medicine market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Precision Medicine Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Big Data Analytics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Bioinformatics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Gene Sequencing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Drug Discovery
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Companion Diagnostics
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Central Nervous System (CNS)
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Immunology
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Respiratory Medicine
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Infections
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Diagnostic Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharma and Biotech Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Healthcare IT Firms
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 AstraZeneca plc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bayer AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 bioMerieux SA
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Bristol-Myers Squibb Company
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Eli Lilly and Company
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 F. Hoffmann-La Roche AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 SWOT Analysis
    • 15.3.7 Illumina Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Laboratory Corporation of America Holdings
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Merck KGaA
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Novartis AG
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Pfizer Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Qiagen N.V.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Quest Diagnostics Incorporated
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis
    • 15.3.14 Thermo Fisher Scientific Inc.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials
      • 15.3.14.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Precision Medicine Market: Major Drivers and Challenges
  • Figure 2: Global: Precision Medicine Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Precision Medicine Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Precision Medicine Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Precision Medicine Market: Breakup by Technology (in %), 2022
  • Figure 6: Global: Precision Medicine Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Precision Medicine Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Precision Medicine Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Precision Medicine (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Precision Medicine (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Precision Medicine (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Precision Medicine (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Precision Medicine (Services) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Precision Medicine (Services) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Precision Medicine (Big Data Analytics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Precision Medicine (Big Data Analytics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Precision Medicine (Bioinformatics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Precision Medicine (Bioinformatics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Precision Medicine (Gene Sequencing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Precision Medicine (Gene Sequencing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Precision Medicine (Drug Discovery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Precision Medicine (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Precision Medicine (Companion Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Precision Medicine (Companion Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Precision Medicine (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Precision Medicine (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Precision Medicine (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Precision Medicine (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Precision Medicine (Central Nervous System-CNS) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Precision Medicine (Central Nervous System-CNS) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Precision Medicine (Immunology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Precision Medicine (Immunology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Precision Medicine (Respiratory Medicine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Precision Medicine (Respiratory Medicine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Precision Medicine (Infections) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Precision Medicine (Infections) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Precision Medicine (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Precision Medicine (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Precision Medicine (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Precision Medicine (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Global: Precision Medicine (Diagnostic Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Global: Precision Medicine (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Global: Precision Medicine (Pharma and Biotech Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Global: Precision Medicine (Pharma and Biotech Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Global: Precision Medicine (Healthcare IT Firms) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Global: Precision Medicine (Healthcare IT Firms) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Global: Precision Medicine (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Global: Precision Medicine (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: North America: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: North America: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: United States: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: United States: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Canada: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Canada: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Asia-Pacific: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Asia-Pacific: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: China: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: China: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Japan: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Japan: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: India: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: India: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: South Korea: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: South Korea: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Australia: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Australia: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Indonesia: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Indonesia: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Others: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Others: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Europe: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Europe: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Germany: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Germany: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: France: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: France: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: United Kingdom: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: United Kingdom: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Italy: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Italy: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Spain: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Spain: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Russia: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Russia: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Others: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Others: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Latin America: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Latin America: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Brazil: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 90: Brazil: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 91: Mexico: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 92: Mexico: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 93: Others: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 94: Others: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 95: Middle East and Africa: Precision Medicine Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 96: Middle East and Africa: Precision Medicine Market: Breakup by Country (in %), 2022
  • Figure 97: Middle East and Africa: Precision Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 98: Global: Precision Medicine Industry: SWOT Analysis
  • Figure 99: Global: Precision Medicine Industry: Value Chain Analysis
  • Figure 100: Global: Precision Medicine Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Precision Medicine Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Precision Medicine Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Precision Medicine Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 4: Global: Precision Medicine Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Precision Medicine Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Precision Medicine Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Precision Medicine Market: Competitive Structure
  • Table 8: Global: Precision Medicine Market: Key Players